Overall survival outcomes with first-line continuous ibrutinib and fixed-duration ibrutinib-venetoclax treatments in patients with chronic lymphocytic leukemia: Comparison with an age-matched European population / Ghia, P., Ysebaert, L., Janssens, A., Stilgenbauer, S., Fouad, M., Schioppa, C.A., Hernandez-Rivas, J.-A., Tedeschi, A.. - In: HEMASPHERE. - ISSN 2572-9241. - 9:10(2025). [10.1002/hem3.70246]
Overall survival outcomes with first-line continuous ibrutinib and fixed-duration ibrutinib-venetoclax treatments in patients with chronic lymphocytic leukemia: Comparison with an age-matched European population
Ghia P.
Primo
;
2025-01-01
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
HemaSphere - 2025 - Ghia - Overall survival outcomes with first‐line continuous ibrutinib and fixed‐duration.pdf
accesso aperto
Tipologia:
PDF editoriale (versione pubblicata dall'editore)
Licenza:
Creative commons
Dimensione
712.53 kB
Formato
Adobe PDF
|
712.53 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
